全文获取类型
收费全文 | 373篇 |
免费 | 12篇 |
国内免费 | 15篇 |
出版年
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 10篇 |
2015年 | 26篇 |
2014年 | 15篇 |
2013年 | 23篇 |
2012年 | 46篇 |
2011年 | 53篇 |
2010年 | 28篇 |
2009年 | 8篇 |
2008年 | 9篇 |
2007年 | 10篇 |
2006年 | 5篇 |
2005年 | 35篇 |
2004年 | 21篇 |
2003年 | 13篇 |
2002年 | 15篇 |
2001年 | 17篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 8篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1943年 | 1篇 |
排序方式: 共有400条查询结果,搜索用时 171 毫秒
31.
32.
Parsons PE Matthay MA Ware LB Eisner MD;National Heart Lung Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network 《American journal of physiology. Lung cellular and molecular physiology》2005,288(3):L426-L431
Ventilator-induced lung injury (VILI) is an inflammatory process that can be attenuated by lung protective ventilation strategies. Our objectives to further investigate the pathogenesis of ALI and VILI and the mechanism of lung protection in these syndromes were: 1) to determine if plasma measurements of soluble TNF receptor I (sTNFRI) and II (sTNFRII) would predict the development of ALI and mortality in a small single center trial; 2) to test the predictive value of these markers and of TNF-alpha in a larger, broader group of patients with ALI; 3) to test the hypothesis that low tidal volume ventilation (LTVV) would be associated with a decrease in plasma levels of TNF-alpha, sTNFRI, and sTNFRII. In the single center study, sTNFRI and II levels were higher in patients at risk for and with ALI, but they did not predict the development of the syndrome. In the multicenter trial sTNFRI and II were strongly associated with mortality (OR 5.76/1 log10 increment in receptor level; 95% CI 2.63-12.6 and OR 2.58; 95% CI 1.05-6.31, respectively) and morbidity measured as fewer nonpulmonary organ failure-free and ventilator-free days. The LTVV strategy was associated with an attenuation of plasma sTNFRI levels. In vitro, stimulated A549 cells release sTNFRI but not sTNRFII. In conclusion, plasma levels of sTNFRI and II can serve as biomarkers for morbidity and mortality in patients with ALI. Furthermore, LTVV is associated with a specific decrease in sTNFRI levels. This suggests that one beneficial effect of LTVV may be to attenuate alveolar epithelial injury. 相似文献
33.
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies 总被引:26,自引:0,他引:26
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
CHEK Breast Cancer Case-Control Consortium 《American journal of human genetics》2004,74(6):1175-1182
Previous studies of families with multiple cases of breast cancer have indicated that a frameshift alteration in the CHEK2 gene, 1100delC, is associated with an elevated frequency of breast cancer in such families, but the risk associated with the variant in other situations is uncertain. To evaluate the breast cancer risk associated with this variant, 10,860 breast cancer cases and 9,065 controls from 10 case-control studies in five countries were genotyped. CHEK2*1100delC was found in 201 cases (1.9%) and 64 controls (0.7%) (estimated odds ratio 2.34; 95% CI 1.72–3.20; P=.0000001). There was some evidence of a higher prevalence of CHEK2*1100delC among cases with a first-degree relative affected with breast cancer (odds ratio 1.44; 95% CI 0.93–2.23; P=.10) and of a trend for a higher breast cancer odds ratio at younger ages at diagnosis (P=.002). These results confirm that CHEK2*1100delC confers an increased risk of breast cancer and that this risk is apparent in women unselected for family history. The results are consistent with the hypothesis that CHEK2*1100delC multiplies the risks associated with susceptibility alleles in other genes to increase the risk of breast cancer. 相似文献
34.
WH Demczuk I Martin A Griffith B Lefebvre A McGeer A Shane GG Zhanel GJ Tyrrell MW Gilmour Toronto Invasive Bacterial Diseases Network Canadian Public Health Laboratory Network 《Canadian journal of microbiology》2012,58(8):1008-1017
A baseline serotype distribution was established by age and region for 2058 invasive Streptococcus pneumoniae isolates collected during the implementation period of the 13-valent pneumococcal conjugate vaccine (PCV13) program in many parts of Canada in 2010. Serotypes 19A, 7F, and 3 were the most prevalent in all age groups, accounting for 57% in <2 year olds, 62% in 2-4 year olds, 45% in 5-14?year olds, 44% in 15-49?year olds, 41% in 50-64?year olds, and 36% in ≥65?year olds. Serotype 19A was most predominant in Western and Central Canada representing 15% and 22%, respectively, of the isolates from those regions, whereas 7F was most common in Eastern Canada with 20% of the isolates. Other prevalent serotypes include 15A, 23B, 12F, 22F, and 6C. PCV13 serotypes represented 65% of the pneumococci isolated from?<2 year olds, 71% of 2-4 year olds, 61% of 5-14 year olds, 60% of 15-49 year olds, 53% of 50-64 year olds, and 49% of the?≥65?year olds. Continued monitoring of invasive pneumococcal serotypes in Canada is important to identify epidemiological trends and assess the impact of the newly introduced PCV13 vaccine on public health. 相似文献
35.
Stelzner M Helmrath M Dunn JC Henning SJ Houchen CW Kuo C Lynch J Li L Magness ST Martin MG Wong MH Yu J;NIH Intestinal Stem Cell Consortium 《American journal of physiology. Gastrointestinal and liver physiology》2012,302(12):G1359-G1363
Many advances have been reported in the long-term culture of intestinal mucosal cells in recent years. A significant number of publications have described new culture media, cell formations, and growth patterns. Furthermore, it is now possible to study, e.g., the capabilities of isolated stem cells or the interactions between stem cells and mesenchyme. However, at the moment there is significant variation in the way these structures are described and named. A standardized nomenclature would benefit the ability to communicate and compare findings from different laboratories using the different culture systems. To address this issue, members of the NIH Intestinal Stem Cell Consortium herein propose a systematic nomenclature for in vitro cultures of the small and large intestine. We begin by describing the structures that are generated by preparative steps. We then define and describe structures produced in vitro, specifically: enterosphere, enteroid, reconstituted intestinal organoid, induced intestinal organoid, colonosphere, colonoid, and colonic organoid. 相似文献
36.
Ho Dang Trung N Le Thi Phuong T Wolbers M Nguyen Van Minh H Nguyen Thanh V Van MP Thieu NT Van TL Song DT Thi PL Thi Phuong TN Van CB Tang V Ngoc Anh TH Nguyen D Trung TP Thi Nam LN Kiem HT Thi Thanh TN Campbell J Caws M Day J de Jong MD Van Vinh CN Van Doorn HR Tinh HT Farrar J Schultsz C;VIZIONS CNS Infection Network 《PloS one》2012,7(5):e37825
37.
38.
JP Souza JG Cecatti SM Haddad MA Parpinelli ML Costa L Katz L Say;Brazilian Network for Surveillance of Severe Maternal Morbidity 《PloS one》2012,7(8):e44129
Objectives
To validate the WHO maternal near-miss criteria and develop a benchmark tool for severe maternal morbidity assessments.Methods
In a multicenter cross-sectional study implemented in 27 referral maternity hospitals in Brazil, a one-year prospective surveillance on severe maternal morbidity and data collection was carried out. Diagnostic accuracy tests were used to assess the validity of the WHO maternal near-miss criteria. Binary logistic regression was used to model the death probability among women with severe maternal complications and benchmark the management of severe maternal morbidity.Results
Of the 82,388 women having deliveries in the participating health facilities, 9,555 women presented pregnancy-related complications, including 140 maternal deaths and 770 maternal near misses. The WHO maternal near-miss criteria were found to be accurate and highly associated with maternal deaths (Positive likelihood ratio 106.8 (95% CI 99.56–114.6)). The maternal severity index (MSI) model was developed and found to able to describe the relationship between life-threatening conditions and mortality (Area under the ROC curve: 0.951 (95% CI 0.909–0.993)).Conclusion
The identification of maternal near-miss cases using the WHO list of pregnancy-related life-threatening conditions was validated. The MSI model can be used as a tool for benchmarking the performance of health services managing women with severe maternal complications and provide case-mix adjustment. 相似文献39.
T Kirchhoff MM Gaudet AC Antoniou L McGuffog MK Humphreys AM Dunning SE Bojesen BG Nordestgaard H Flyger D Kang KY Yoo DY Noh SH Ahn T Dork P Schürmann JH Karstens P Hillemanns FJ Couch J Olson C Vachon X Wang A Cox I Brock G Elliott MW Reed B Burwinkel A Meindl H Brauch U Hamann YD Ko;GENICA Network A Broeks MK Schmidt LJ Van 't Veer LM Braaf N Johnson O Fletcher L Gibson J Peto C Turnbull S Seal A Renwick N Rahman PE Wu JC Yu CN Hsiung CY Shen MC Southey JL Hopper F Hammet T Van Dorpe 《PloS one》2012,7(6):e35706
Recently, a locus on chromosome 6q22.33 (rs2180341) was reported to be associated with increased breast cancer risk in the Ashkenazi Jewish (AJ) population, and this association was also observed in populations of non-AJ European ancestry. In the present study, we performed a large replication analysis of rs2180341 using data from 31,428 invasive breast cancer cases and 34,700 controls collected from 25 studies in the Breast Cancer Association Consortium (BCAC). In addition, we evaluated whether rs2180341 modifies breast cancer risk in 3,361 BRCA1 and 2,020 BRCA2 carriers from 11 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Based on the BCAC data from women of European ancestry, we found evidence for a weak association with breast cancer risk for rs2180341 (per-allele odds ratio (OR)?=?1.03, 95% CI 1.00-1.06, p?=?0.023). There was evidence for heterogeneity in the ORs among studies (I(2)?=?49.3%; p?=?<0.004). In CIMBA, we observed an inverse association with the minor allele of rs2180341 and breast cancer risk in BRCA1 mutation carriers (per-allele OR?=?0.89, 95%CI 0.80-1.00, p?=?0.048), indicating a potential protective effect of this allele. These data suggest that that 6q22.33 confers a weak effect on breast cancer risk. 相似文献
40.
Matthieu Domenech de Cellès Jér?me Salomon Anne Marinier Christine Lawrence Jean-Louis Gaillard Jean-Louis Herrmann Didier Guillemot 《PloS one》2012,7(9)
Infections caused by multidrug-resistant bacteria are a major concern in hospitals. Current infection-control practices legitimately focus on hygiene and appropriate use of antibiotics. However, little is known about the intrinsic abilities of some bacterial strains to cause outbreaks. They can be measured at a population level by the pathogen’s transmission rate, i.e. the rate at which the pathogen is transmitted from colonized hosts to susceptible hosts, or its reproduction number, counting the number of secondary cases per infected/colonized host. We collected data covering a 20-month surveillance period for carriage of multidrug-resistant Acinetobacter baumannii (MDRAB) in a surgery ward. All isolates were subjected to molecular fingerprinting, and a cluster analysis of profiles was performed to identify clonal groups. We then applied stochastic transmission models to infer transmission rates of MDRAB and each MDRAB clone. Molecular fingerprinting indicated that 3 clonal complexes spread in the ward. A first model, not accounting for different clones, quantified the level of in-ward cross-transmission, with an estimated transmission rate of 0.03/day (95% credible interval [0.012–0.049]) and a single-admission reproduction number of 0.61 [0.30–1.02]. The second model, accounting for different clones, suggested an enhanced transmissibility of clone 3 (transmission rate 0.047/day [0.018–0.091], with a single-admission reproduction number of 0.81 [0.30–1.56]). Clones 1 and 2 had comparable transmission rates (respectively, 0.016 [0.001–0.045], 0.014 [0.001–0.045]). The method used is broadly applicable to other nosocomial pathogens, as long as surveillance data and genotyping information are available. Building on these results, more epidemic clones could be identified, and could lead to follow-up studies dissecting the functional basis for variation in transmissibility of MDRAB lineages. 相似文献